CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,364 shares (to pay taxes)
- 4 Other disposition CFO disposed of 2,360 shares (other)
- 4 Other disposition President & COO disposed of 16,549 shares (other)
- 4 Other disposition Chief Accounting Officer disposed of 1,415 shares (other)
- 4 Other disposition CEO disposed of 11,318 shares (other)
- 4 Other disposition CFO disposed of 2,360 shares (other)
- 4 Other disposition President & COO disposed of 18,261 shares (other)
- 4 Other disposition CEO disposed of 12,489 shares (other)
- 4 Other disposition Chief Accounting Officer disposed of 1,563 shares (other)
- 4 Other disposition Director disposed of 687 shares (other)
- 4 Grant or award Director acquired 2,269 shares (grant or award)
- 4 Grant or award Director acquired 1,226 shares (grant or award)
- 4 Grant or award Director acquired 1,269 shares (grant or award)
- 4 Planned sale Chief Operating Officer sold 1,200,000 shares at an average $10.43 ($12,520,990)
- 4 Open-market buy Director bought 1,526,316 shares at $38.00 ($58,000,008)
- 4 Other disposition CFO disposed of 2,483 shares (other)
- 4 Open-market sale Director sold 6,896,144 shares at $11.55 ($79,650,463)
- 4 Open-market sale 10% owner sold 10,000,000 shares at $12.60 ($126,000,000)
- 4 Open-market sale Director sold 10,000,000 shares at $11.55 ($115,500,000)
- 4 Open-market sale 10% owner sold 10,000,000 shares at $11.55 ($115,500,000)
Page 15 of 26 · 511 filings